elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36864836-FEDF4507-0A0A-486C-8AB3-60516B706CBD
Q36864836-FEDF4507-0A0A-486C-8AB3-60516B706CBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36864836-FEDF4507-0A0A-486C-8AB3-60516B706CBD
Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?
P2860
Q36864836-FEDF4507-0A0A-486C-8AB3-60516B706CBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36864836-FEDF4507-0A0A-486C-8AB3-60516B706CBD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e81af2ca659bfd3b52f06d148925dab1cf9e09c0
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease